Page last updated: 2024-11-05

trazodone and Torsade de Pointes

trazodone has been researched along with Torsade de Pointes in 2 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ryan, K1
Benz, P1
Zosel, A1
Farkas, A1
Theobald, J1
Chung, KJ1
Wang, YC1
Liu, BM1
Supernaw, RB1

Other Studies

2 other studies available for trazodone and Torsade de Pointes

ArticleYear
QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes".
    Cardiovascular toxicology, 2022, Volume: 22, Issue:9

    Topics: Amitriptyline; Arrhythmias, Cardiac; Diphenhydramine; Electrocardiography; Flecainide; Humans; Long

2022
Management of ventricular dysrhythmia secondary to trazodone overdose.
    The Journal of emergency medicine, 2008, Volume: 35, Issue:2

    Topics: Adult; Anti-Arrhythmia Agents; Drug Overdose; Electric Countershock; Female; Humans; Magnesium Sulfa

2008